Concepedia

Publication | Open Access

Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine

DOIFull Paper Access

15

Citations

36

References

2021

Year

Sylvester Dassah, Bright Adu, Sodiomon B. Sirima, Benjamin Mordmüller, Ulysse Ateba Ngoa, Frank Atuguba, Fareed K. N. Arthur, Benedicta Ayiedu Mensah, Mark Kaddumukasa, Peter Fibiger Bang,
Vaccine

Abstract

GMZ2/alum was well tolerated. Follow-up over 2 years confirmed a low level of vaccine efficacy with slightly higher efficacy in older children, which suggests GMZ2 may act in concert with naturally acquired immunity.

References

YearCitations

Page 1